Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 111
Cardiovascular Drugs 86
Vaccines 47
Central Nervous System Drugs 39
Hematological Drugs 36
Pharmaceuticals 34
Drug Discovery 33
Endocrine and Metabolic Disorders Drugs 31
Immune Disorders Drugs 27
Genomics 25
Musculoskeletal Disorders Drugs 25
Leukemia Drugs 24
Analgesics 24
Biopharmaceuticals 23
Clinical Trials 21
Infectious Diseases Drugs 20
Contrast Media 19
Oncology 17
Skin Cancer Drugs 16
Biotechnology 15
Lung Cancer Drugs 14
Infusions and Injectables 14
Antibiotics 14
Women's Health 13
Enzymes 13
Breast Cancer Drugs 12
Alzheimer's Disease Drugs 12
Diabetes Drugs 11
Liver and Kidney Disorders Drugs 11
Brain Cancer Drugs 10
Hematology 10
Diagnostics 9
Gastrointestinal Drugs 9
Respiratory Drugs 9
Allergy and Immunology 8
Healthcare Services 8
Biosimilars and Biosuperiors 8
Colon Cancer Drugs 7
Ultrasound 6
Cardiology 6
Urological Disorders Drugs 6
Pharmaceutical Manufacturing 6
Animal Pharmaceuticals 5
Optical Disorders Drugs 5
Lymphoma Drugs 5
Managed Care 5
Stem Cells 5
Thyroid Cancer Drugs 5
Pharmaceutical Intermediates 4
Pulmonary Medicine 4
Neurology 4
Liver Cancer Drugs 4
Ovarian Cancer Drugs 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Infectious Disease Testing 4
Medical Devices 4
Drug Delivery 4
Gastroenterology 4
Dermatological Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Pancreatic Cancer Drugs 3
Pediatrics 3
HIV/AIDS Drugs 3
Company Reports 2
Therapeutic Area 2
Urology and Nephrology 2
Prostate Cancer Drugs 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Neurology Devices 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Anti-Obesity Drugs 2
Palliative Care 2
Bronchitis Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Bladder Cancer Drugs 1
Proteomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Other Healthcare Facilities 1
Nanomedicine 1
Laboratory Equipment 1
Endocrinology 1
Acne Drugs 1
Asthma Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



285 reviews

768 Results (Page 26 of 39)
- Relevance
  Sort by

Melanoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Metastatic Melanoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Radiation Toxicity - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1779EUR$2,000USD£1,527GBP

Targeted Drug Delivery Market - Global Strategic Business Report

 Report
September 2026
168 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

FLT3 Antagonists Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3153EUR$3,545USD£2,707GBP

€3503EUR$3,939USD£3,008GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global TROP2 Antibody Market Opportunity & Clinical Trials Insight 2030

 Report
February 2025
200 Pages
Global

From

€2490EUR$2,800USD£2,138GBP

United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2033

 Report
January 2025
230 Pages
United States

From

€3113EUR$3,500USD£2,672GBP

Analyzing the Global Pharmaceutical Industry 2022

 Report
November 2022
500 Pages
Global

From

€1334EUR$1,500USD£1,145GBP

Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Acute Myeloid Leukemia Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Multiple Myeloma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Myelodysplastic Syndrome Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3993EUR$4,490USD£3,428GBP

Esophageal Squamous Cell Carcinoma Market - Global Strategic Business Report

 Report
September 2026
275 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Breast Adenocarcinoma Treatment - Global Strategic Business Report

 Report
September 2026
294 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Lung Adenocarcinoma Treatment - Global Strategic Business Report

 Report
September 2026
291 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Blockbuster Oncology Brands - Global Strategic Business Report

 Report
September 2026
284 Pages
Global

From

€5203EUR$5,850USD£4,467GBP

Therapeutics for Women's Health: Technologies and Global Markets

 Report
March 2025
159 Pages
Global

From

€4136EUR$4,650USD£3,550GBP

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

 Report
January 2025
388 Pages
Global

From

€2392EUR$2,690USD£2,054GBP

Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application, By Technology, By Regional Outlook and Forecast, 2022 - 2028

 Report
May 2022
188 Pages
Global

From

€3202EUR$3,600USD£2,749GBP

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1779EUR$2,000USD£1,527GBP

768 Results (Page 26 of 39)
- 1
- 24
- 25
- 26
- 27
- 28

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.